266 
Editorial. 
Am.  Jour.  Pharm. 
May,  1893. 
Subjects  Proposed  for  Papers,  Reports  aiid  Discussion. 
SECTION  I.— HISTORICAL  AND  ETHICAL  PHARMACY. 
(1)  The  condition  of  pharmacy  four  centuries  ago  as  contrasted  with  its 
present  status. 
(2)  The  history  of  pharmacy  and  pharmaceutical  institutions  in  the  United 
States. 
(3)  The  ethics  of  the  practice  of  pharmacy,  and  the  mutual  relations  between 
physician  and  pharmacist,  and  between  pharmacists  and  the  public. 
(4)  The  influence  exerted  upon  the  practice  of  pharmacy  by  the  introduction 
of  chemicals  and  other  medicinal  substances  controlled  or  limited  by  patents, 
copyrights,  trade-marks,  or  other  legal  restrictions,  but  which  are  commonly 
ordered  by  physicians  in  their  prescriptions. 
Should  such  limitations  as  foster  monopoly  in  the  manufacture  and  sale  of 
such  products  be  removed  in  the  interest  of  the  public  good  ? 
(5)  The  relations  of  pharmacists  to  public  sanitation. 
(6)  Statistics  of  the  present  number  of  pharmacies  in  proportion  to  popu- 
lation in  various  countries,  and  of  imports  and  exports  of  crude  drugs,  medi- 
cinal chemicals,  and  pharmaceutical  preparations  during  the  last  half-century. 
SECTION  II. — PHARMACEUTICAL  EDUCATION  AND  LEGISLATION. 
(1)  Statistics  giving  the  number  of  schools  or  colleges  of  pharmacy  in  each 
country,  and  the  total  number  of  students  pursuing  pharmaceutical  courses. 
(2)  How  do  the  education  and  the  professional  and  social  position  of  pharma- 
cists compare  with  those  of  other  professions  ? 
(3)  What  legislation,  if  any,  is  at  present  most  needed  for  the  advancement 
of  the  best  interests  of  pharmacy  ? 
(4)  To  what  extent  is  official  supervision  of  drug-stores  necessary  or 
beneficial  ? 
SECTION  III. — PHARMACOPCEIAL  QUESTIONS. 
(1)  The  proper  scope  of  a  national  pharmacopoeia. 
(2)  What  improvements,  if  any,  are  desirable  and  practicable  in  pharma- 
copceial nomenclature?  Is  a  nearer  approach  to  international  uniformity 
possible  ? 
(3)  What  would  be  an  ideal  pharmacopoeia  ? 
(4)  What  progress  has  been  made  towards  the  preparation  of  an  international 
pharmacopoeia  for  potent  remedies  ? 
What  action,  if  any,  should  be  taken  in  reference  to  this  subject? 
(5)  Have  the  influence  and  co-operation  of  pharmacists  increased  in  the  work 
of  pharmacopceial  revision  in  the  various  countries  ?  What  proportion  of  the 
membership  of  the  pharmacopceial  revision  committee  or  commission  of  your 
country  consists  of  pharmacists  ? 
(6)  Should  any  substance,  the  manufacture  or  sale  of  which  is  restricted  by 
any  patent,  copyright,  or  trade-mark,  be  admitted  into  any  national  pharma- 
copoeia ?    If  so,  under  what  conditions  ? 
(7)  What  consideration  should  determine  the  introduction  into  the  Pharma- 
copoeia of  a  new  remedy,  or  the  retention  or  rejection  of  one  already  in  it? 
